$FPRX FIVE PRIME THERAPEUTICS, INC. Insiders

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in FIVE PRIME THERAPEUTICS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of current and past insiders in FIVE PRIME THERAPEUTICS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.

FIVE PRIME THERAPEUTICS, INC. Insiders

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
ADAGE CAPITAL PARTNERS GP LLC10% Owner2,539,949115,262,886Oct 19 2015
ATWOOD BRIAN GDirector00Jun 16 2015
ATWOOD BRIAN GDirector1,092,15249,561,858May 20 2014
Baker Kevin PaulSVP, Development Sciences78,1843,547,990shares bought: 23,656 / shares sold: -20,736 BUYFeb 28 2018
Belsky MarcSenior Vice President and CFO16,314740,329shares bought: 107,428 / shares sold: -91,923 BUYFeb 28 2018
Belsky MarcSVP and CFO00Aug 26 2014
BERGER FRANKLIN MDirector00shares bought: 11,090 / shares sold: -84,980 STRONG SELLApr 19 202115 months ago
BERGER FRANKLIN MDirector37,0001,679,060Jan 29 2015
Borges LuisSVP, Research64,8882,944,617shares bought: 17,656 / shares sold: -19,390 SELLMar 03 2017
BVF PARTNERS L P/IL10% Owner670,69530,436,139shares bought: 4,177,168 / shares sold: -7,393,340 STRONG SELLNov 13 202020 months ago
Civik ThomasPresident and CEO00shares bought: 75,000 / shares sold: -80,059 SELLApr 19 202115 months ago
Cohen Fred EDirector24,8071,125,742May 23 2016
Cohen Fred EDirector1125,083Jul 03 2014
Collins Helen LouiseEVP and Chief Medical Officer69,5473,156,043shares bought: 148,844 / shares sold: -187,028 SELLApr 19 202115 months ago
Dhingra KapilDirector00Apr 19 202115 months ago
Douglas R LeeDirector1,22055,364shares bought: 1,220 / shares sold: 0 BUYOct 13 2016
Douglas R LeeDirector4,184189,870May 21 2014
Gujrathi SheilaDirector00May 14 2018
Hambleton JulieEVP & Chief Medical Officer84,8113,848,723Nov 13 2015
Irving BryanEVP, Chief Scientific Officer30,5331,385,588shares bought: 34,750 / shares sold: -4,217 STRONG BUYMay 16 2019
Jensen PederDirector4,065184,470shares bought: 20,325 / shares sold: -20,325 HOLDApr 19 202115 months ago
Jensen PederDirector00May 20 2014
Kavanaugh William MichaelSVP & Chief Scientific Officer00Aug 26 2014
Knickerbocker Aron MarcPresident & CEO42,0571,908,547shares bought: 132,607 / shares sold: -57,868 STRONG BUYSep 04 2019
Lyons-Williams LoriDirector00Apr 19 202115 months ago
MCDADE MARKDirector10,162461,152shares bought: 12,601 / shares sold: 0 STRONG BUYMay 14 2018
MCDADE MARKDirector00May 20 2014
Nicholson Garry ADirector00Apr 19 202115 months ago
RINGO WILLIAM RDirector00shares bought: 18,400 / shares sold: -18,400 HOLDApr 19 202115 months ago
RINGO WILLIAM RDirector00Oct 02 2014
Sarena Francis WillardChief Strategy Officer121,5425,515,576shares bought: 222,386 / shares sold: -324,733 SELLApr 19 202115 months ago
Sarena Francis WillardSVP, Gen Counsel & Secretary00Aug 26 2014
SCHAFER CAROLDirector00Apr 19 202115 months ago
Sikorski Robert StevenSVP and Chief Medical Officer104,1584,726,690shares bought: 40,156 / shares sold: -38,154 BUYMar 03 2017
SMITH DAVID VExecutive Vice President & CFO138,9476,305,415shares bought: 158,000 / shares sold: -176,012 SELLApr 19 202115 months ago
White DavidSee Remarks00shares bought: 30,000 / shares sold: -45,000 SELLApr 19 202115 months ago
Williams Lewis TDirector455,33620,663,148shares bought: 395,753 / shares sold: -280,392 BUYSep 04 2019
Williams Lewis TPresident and CEO356,50316,178,106Nov 04 2014